
Loading, please wait...

Loading, please wait...

Medanta hospital expansion is driving significant financial growth for Global Health Limited. The company reported a 25.3 per cent year-on-year rise in total income during the fourth quarter. Consequently, revenue reached Rs 1,195 crore for the period ending March 2026. This performance showcases the robust demand for multispecialty healthcare services across India's urban centers.
The hospital chain's net profit jumped nearly 40 per cent to Rs 141 crore. Meanwhile, EBITDA increased by 17.4 per cent to reach Rs 290 crore. This growth occurred despite various operational challenges in the global market. Furthermore, the average revenue per occupied bed (ARPOB) increased by 4.8 per cent. Doctors and administrators view these metrics as indicators of high-complexity clinical work. Additionally, international patient revenue rose by 22 per cent YoY, reaching Rs 67 crore. However, flight disruptions due to regional conflicts caused a slight sequential decline in foreign patient numbers.
Medanta hospital expansion includes both brownfield and greenfield developments. Specifically, the group added 86 new beds in Patna and Noida during the last quarter. Looking ahead, the company expects to add 500 beds across its existing facilities within 12 months. Moreover, five greenfield projects will provide 2,700 additional beds over the next four years. This strategy aims to strengthen Medanta's presence in key regional markets. Consequently, the group is preparing for a significant increase in its total clinical capacity. Pankaj Sahni, Group CEO, highlighted that these projects remain on track to meet rising healthcare demands.
The newly inaugurated Noida facility showed remarkable progress in operational efficiency. For instance, quarterly losses at this site narrowed from Rs 32 crore to Rs 23.6 crore. The facility now operates 382 beds and 14 operating theatres. Similarly, bed occupancy across the group stood at 62 per cent. Out-patient counts also saw a significant increase of 18.7 per cent. These figures suggest that patients increasingly trust corporate hospital chains for specialized care. Overall, the financial year 2026 ended with a total income of Rs 4,508 crore for the group.
Q1: How many beds does Medanta plan to add in the future?
Medanta plans to add 500 beds across existing hospitals in the next year. Additionally, it will add 2,700 beds through five greenfield projects over the next three to four years.
Q2: What was the increase in Medanta's net profit for Q4 FY26?
Medanta reported a 39.7 per cent jump in net profit, which rose to Rs 141 crore compared to Rs 101 crore in the previous year's quarter.
Q3: Which facilities recently added new beds?
During the fourth quarter, Medanta added 32 new beds in Patna and 54 beds in its Noida facility.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Medanta posts ₹1,195 crore revenue in Q4 FY26 with a 40% profit surge. The group plans to add 3,200 beds through greenfield projects and existing facility g...
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A 25-year multi-institutional cohort reveals high recurrence rates in pediatric giant cell tumor of bone, particularly in patients with open physes and bone marrow edema on preoperative MRI. Early surveillance and careful balance between growth plate preservation and tumor clearance are essential.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today